Volume : 11, Issue : 11, November – 2024
Title:
ROLE OF PHARMACISTS IN IMPROVING MEDICATION SAFETY IN PATIENTS WITH CANCER: A SYSTEMATIC REVIEW
Authors :
Bashayer Mohammed Alshehail , Maryam Abdulmonem Bukhamsin , Ibtihal Adel Almashhadi , Kawthar Essa Alkhalifah , Zahra Abdulraouf Alrashed , May Mohammed Al.Idrissi , Atheer Abdulmajeed Alabbad , Zainab Abdulrzzak Aldajani , Nourah mohammed almuseleem , Joud basem albuali
Abstract :
Objectives: To evaluate the role of pharmacists in improving medication safety in cancer patients, examining the effectiveness of interventions led by pharmacists and their impact on patient outcomes. Methods: To locate research that met the inclusion criteria, a thorough computerized search of relevant databases was carried out. A comprehensive search was carried out on PubMed, SCOPUS, Science Direct, Cochrane Library, and Web of Science to locate relevant material. Results: The dataset comprised seven studies involving 11,329 cancer patients, with 4332 (38.2%) being male. Pharmacist involvement in oncology care, particularly in medication management, significantly enhances patient safety and treatment outcomes. Strategies like medication charting, opioid management, and chemotherapy verification prevent errors and improve well-being. Older cancer patients especially benefit from pharmaceutical care, with interventions identifying and addressing drug-related problems (DRPs). Collaboration between pharmacists, oncologists, and interdisciplinary teams optimizes medication use, ensures compliance, and reduces treatment risks across both inpatient and outpatient settings. Conclusion: The role of pharmacists in improving drug safety and treatment outcomes in oncology care is undeniable. Their interventions, particularly in managing complex regimens and addressing DRPs, have proven to be crucial for patient well-being. Strengthening collaboration between pharmacists and other healthcare providers can further enhance patient outcomes, especially for vulnerable populations such as the elderly. As the healthcare landscape continues to evolve, the role of pharmacists should be expanded and standardized to maximize their positive impact on patient care.
Keywords: Pharmacists; Medication Safety; Medication errors; Adverse Drug Reactions; Pharmacological Interventions; Systematic review.
Cite This Article:
Please cite this article in press Bashayer Mohammed Alshehail et al., Role Of Pharmacists In Improving Medication Safety In Patients With Cancer: A Systematic Review..,Indo Am. J. P. Sci, 2024; 11 (11).
Number of Downloads : 10
References:
1. Shams M, Abdallah S, Alsadoun L, Hamid YH, Gasim R, Hassan A. Oncological Horizons: The Synergy of Medical and Surgical Innovations in Cancer Treatment. Cureus. 2023;15(11):e49249. Published 2023 Nov 22. doi:10.7759/cureus.49249
2. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37-46. Published 2017 Jan 25. doi:10.2147/IPRP.S108047
3. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases. J Multidiscip Healthc. 2021;14:1701-1710. Published 2021 Jul 5. doi:10.2147/JMDH.S309938
4. Lopez-Martin C, Garrido Siles M, Alcaide-Garcia J, Faus Felipe V. Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience. Int J Clin Pharm. 2014;36(6):1251-1259. doi:10.1007/s11096-014-0029-4.
5. Lively A, Minard LV, Scott S, Deal H, Lambourne T, Giffin J. Exploring the perspectives of healthcare professionals in delivering optimal oncology medication education. PLoS One. 2020;15(2):e0228571. Published 2020 Feb 12. doi:10.1371/journal.pone.0228571
6. Chalasani SH, Syed J, Ramesh M, Patil V, Pramod Kumar TM. Artificial intelligence in the field of pharmacy practice: A literature review. Explor Res Clin Soc Pharm. 2023;12:100346. Published 2023 Oct 21. doi:10.1016/j.rcsop.2023.100346
7. Chehelgerdi M, Chehelgerdi M, Allela OQB, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169. Published 2023 Oct 9. doi:10.1186/s12943-023-01865-0
8. Lee KMK, Koeper I, Johnson ME, Page A, Rowett D, Johnson J. Multidisciplinary perspectives on roles of hospital pharmacists in tertiary settings: a qualitative study. Int J Qual Health Care. 2024;36(1):mzad110. doi:10.1093/intqhc/mzad110
9. Alim U, Austin-Bishop N, Cummings G. Pharmacists in a complex chronic disease management clinic. Can J Hosp Pharm. 2016;69(6):480–482. doi: 10.4212/cjhp.v69i6.1612
10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International journal of surgery. 2021 Apr 1;88:105906.
11. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Systematic reviews. 2016 Dec;5:1-0.
12. Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J, Lockwood C, Stephenson M, Moola S, Lizarondo L, McArthur A. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). JBI evidence implementation. 2019 Mar 1;17(1):36-43.
13. Tong EY, Edwards GE, Hua PU, Mitra B, Dyk EV, Yip G, Coutsouvelis J, Siderov J, Tran Y, Dooley MJ. Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients. Journal of Oncology Pharmacy Practice. 2024 Jun;30(4):636-41.
14. Anwar A, Malik N, Siddiqui A, Shrestha S, Bhutta OA, Mazhar S, Khan MR, Usman HM. Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer. Journal of Oncology Pharmacy Practice. 2024 Aug 28:10781552241279027.
15. Venancio RG, Magliano ED, Barreto ED. Analysis of pharmaceutical interventions in chemotherapy prescriptions of adult and pediatric patients at an oncology reference institute. Journal of Oncology Pharmacy Practice. 2024 Mar 5:10781552241230630.
16. Fariya S, Mary Martin Daniel PJ, Raj JS, Sureshkumar K, Suthakar M, Muhasaparur Ganesan R. Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India. Journal of Oncology Pharmacy Practice. 2023 Dec;29(8):1836-43.
17. Soggee J, Hunt M, O’Callaghan B, Lam WS, Cannell P, Boardman G, Sunderland B, Czarniak P. Specialist pharmacist consultations with cancer patients in a pharmacist‐led anticancer clinic. Asia‐Pacific Journal of Clinical Oncology. 2023 Aug;19(4):507-16.
18. van Loveren FM, Imholz AL, van’t Riet E, Taxis K, Jansman FG. Prevalence and follow-up of potentially inappropriate medication and potentially omitted medication in older patients with cancer–The PIM POM study. Journal of Geriatric Oncology. 2021 Jan 1;12(1):80-4.
19. Choukroun C, Leguelinel-Blache G, Roux-Marson C, Jamet C, Martin-Allier A, Kinowski JM, Le Guillou C, Richard H, Antoine V. Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer. Journal of geriatric oncology. 2021 Jan 1;12(1):57-63.
20. Zhang J, Xu R, Zhao X, Wang Y, Zhu W, Xiao M, Hu H, Tang L, Shen Z, Guo C. The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients. Translational Cancer Research. 2021 Apr;10(4):1703.
21. Heffner C, Dillaman M, Hill J. Pharmacist-driven medication reconciliation reduces oral oncolytic medication errors during transitions of care. American Journal of Health-System Pharmacy. 2020 Dec 1;77(Supplement_4):S100-4.
22. Ding H, Zheng X, Kong S, Gong L, Ding Q, Huang P. Multidisciplinary intervention incorporating pharmacists in management of opioid‐naive patients with moderate to severe cancer pain. European Journal of Cancer Care. 2020 May;29(3):e13225.
23. Maleki S, Alexander M, Fua T, Liu C, Rischin D, Lingaratnam S. A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies. Journal of Oncology Pharmacy Practice. 2019 Jan;25(1):130-9.
24. Tan Z, Yu Z, Chen K, Liu W, Zhao R. Effects of pharmacist-led clinical pathway/order sets on cancer patients: A systematic review. Frontiers in Pharmacology. 2021 May 21;12:617678.
25. Fentie AM, Huluka SA, Gebremariam GT, Gebretekle GB, Abebe E, Fenta TG. Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: A systematic review and meta-analysis of randomized control trials. Research in Social and Administrative Pharmacy. 2024 Feb 14.